Clinical Trials Browser

Phase 1 × Radiosurgery × Genitourinary × Clear all

NCT04235777 2026-04-20

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

Phase 1 Recruiting

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT04644770 2026-04-13

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

Phase 1 Active not recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT05079698 2026-04-07

A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT06369246 2026-03-09

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

Phase 1 Recruiting

Advanced Prostate Cancer

NCT04943536 2026-02-27

BiolenRT

Phase 1 Active not recruiting

Prostate Adenocarcinoma

NCT01923506 2025-11-26

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT06132945 2025-11-14

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Phase 1 Active not recruiting

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell

NCT01655836 2025-09-11

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT03477864 2025-04-29

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Phase 1 Withdrawn

Prostatic Neoplasms

NCT03835533 2024-04-12

PORTER

Phase 1 Completed

43 enrolled 19 charts

Metastatic Castration-resistant Prostate Cancer

NCT05259319 2023-10-17

IMMUNOs-SBRT

Phase 1 Unknown

GenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT05567770 2023-08-24

ACTION

Phase 1 Withdrawn

Prostate Cancer Metastatic

NCT02572284 2023-01-19

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT02206334 2022-05-25

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Phase 1 Completed

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Breast Neoplasms, Male

NCT03041285 2022-05-11

Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

Phase 1 Terminated

Metastatic Castrate- Resistant Prostate Cancer

NCT02653248 2022-02-09

SBRT for Organ Confined Prostate Cancer

Phase 1 Completed

Adenocarcinoma, Prostatic Neoplasms

NCT02946008 2019-11-27

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT01943188 2017-03-15

Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer

Phase 1 Terminated

Carcinoma, Renal Cell

NCT02410174 2017-01-09

To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors

Phase 1 Terminated

Carcinoma, Renal Cell

NCT00445757 2012-03-20

Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors

Phase 1 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms